XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income (loss) $ 36,853 $ (6,769)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation and amortization 362 306
Stock-based compensation 4,808 78
Amortization of debt issuance costs 14 130
Accretion of debt discount 2,211 40
Change in fair value of derivative liability 1,426 52
Change in fair value of warrants liability 7,363 1,128
Change in fair value of earnout liability (67,008) 0
Changes in operating assets and liabilities:    
Other receivables (214) 954
Grants receivable (16) 87
Prepaid expenses and other current assets (3,677) 3
Accounts payable (1,063) (301)
Accrued expenses 3,173 196
Related party payable 152 205
Net cash used in operating activities (15,616) (3,891)
Cash flows from investing activities    
Purchases of property, plant, and equipment, net of grants (5,113) (1,404)
Net cash used in investing activities (5,113) (1,404)
Cash flows from financing activities    
Proceeds from notes payable, net of debt issuance costs 11,707 906
Proceeds of short-term debt 0 501
Payment of short-term debt (906) 0
Proceeds from Canadian Government Research and Development Program 287 1,205
Issuance of common stock 56 1
Business combination, net of issuance costs paid 467,530 0
Net cash provided by financing activities 478,674 2,613
Effects of foreign exchange rate changes on the balance of cash and cash equivalents, and restricted cash held in foreign currencies (41) 58
Net increase (decrease) in cash and cash equivalents, and restricted cash 457,904 (2,624)
Cash and cash equivalents, and restricted cash, beginning of the period 1,874 3,612
Cash and cash equivalents, and restricted cash, end of the period 459,778 988
Supplemental disclosure of cash flow information    
Conversion of stockholder convertible notes payable to common stock 20,493 0
Reclassification of redeemable convertible preferred stock warrants to common stock 54,267 0
Reclassification of contingently issued equity to liability 203,082 0
Net assets assumed from business combination 81,364 0
Debt discount related to derivative liability 2,196 0
Business combination transaction costs, accrued but not paid $ 609 $ 0